The revolution in genetics, including the decoding of the human genome in 2003 and the 2008 passage of the Genetic Information Nondiscrimination Act (GINA), is in the process of impacting a wide array of legal practice areas, including health and tort law, criminal law, insurance, discrimination, and privacy law.
To explore this area, the MCLE will sponsor a seminar titled The Legal Implications of the Human Genome Project on Thursday, October 2 from 1 to 5 p.m. at Milstein Hall, Boston.
Expert panelists will include: Susan L. Crockin, Crockin Law & Policy Group, LLC; David E. Meier, Todd & Weld LLP; George J. Annas, Boston University School of Public Health; Wendy K. Mariner, Boston University Medical Campus; Philip R. Reilly,Interleukin Genetics Incorporated and Jennifer Rosato, Drexel University.
The audience will learn the state of the science, update on federal law, criminal law issues, intellectual property issues, new torts rules, the impact on HIPPA, and what the future holds.
For additional details and available CLE credits, visit the Bulletin Board of The Metropolitan Corporate Counsel at www.metrocorpcounsel.com.
To register call (800) 966-6253 or visit www.mcle.org.